SCHEMBL17488701

SCHEMBL17488701

Cc1nc2c(F)cc(-c3nc(Nc4ccc(N5CCC(O)CC5)cn4)ncc3F)cc2n1C(C)C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 19/20 0.64
CDK6 Q00534 12/20 0.64
CDK2 P24941 10/20 0.64
CDK9 P50750 5/20 0.64
CCNA2 P20248 4/20 0.64
CCNK O75909 2/20 0.64
CSF1R P07333 1/20 0.64
CDK1 P06493 12/20 0.64
CCNB1 P14635 8/20 0.64
CCNE1 P24864 8/20 0.64
CDK7 P50613 4/20 0.64
CCND3 P30281 3/20 0.64
EGFR P00533 2/20 0.64
CIT O14578 1/20 0.64
GAK O14976 1/20 0.64
DYRK3 O43781 1/20 0.64
CCNT1 O60563 1/20 0.64
STK16 O75716 1/20 0.64
STK10 O94804 1/20 0.64
PRKD3 O94806 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17477188 0.92 CDK4 (0.63) CDK4CDK6CDK2CDK9CCNA2
SCHEMBL17489296 0.92 CDK4 (0.61) CDK4CDK6CDK2CDK9CCNA2
SCHEMBL17488669 0.92 CDK4 (0.61) CDK4CDK6CDK2CDK9CCNA2
SCHEMBL25276066 0.91 CDK4 (0.63) CDK4CDK6CDK2CDK9CCNA2
SCHEMBL17488648 0.91 CDK4 (0.68) CDK4CDK6CDK2CDK9CCNA2
SCHEMBL17488828 0.91 CDK4 (0.69) CDK4CDK6CDK2CDK9CCNA2
SCHEMBL17488712 0.91 CDK4 (0.65) CDK4CDK6CDK2CDK9CCNA2
SCHEMBL17488826 0.90 CDK4 (0.67) CDK4CDK6CDK2CDK9CCNA2
SCHEMBL17489156 0.89 CDK4 (0.62) CDK4CDK6CDK2CDK9CCNA2
SCHEMBL17488783 0.89 CDK4 (0.62) CDK4CDK6CDK2CDK9CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016015605-A1 COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-04 WO disclosed